Vaccinex, Inc.
Records under this name other than the patents Vaccinex, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 41 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,371,352 | Modified Glycolipids and Methods of Making and Using the Same Formerly held In force · High confidence | In force | High confidence | |
| US 12,201,719 | Combination Therapy with SEMAPHORIN-4D Blockade (SEMA4D) and DC1 Therapy Formerly held In force · High confidence | In force | High confidence | |
| US 11,660,330 | Combination Therapy with SEMAPHORIN-4D Blockade (SEMA4D) and DC1 Therapy Formerly held In force · High confidence | In force | High confidence | |
| US 11,597,765 | Use of SEMAPHORIN-4D Binding Molecules for the Treatment of Rett Syndrome Formerly held In force · High confidence | In force | High confidence | |
| US 10,111,950 | Modified Glycolipids and Methods of Making and Using the Same Formerly held Lapsed on the fee record Ended Oct 30, 2026 · Low confidence | Lapsed on the fee record | Ended Oct 30, 2026 | Low confidence |
| US 8,637,026 | ANTI-C35 Antibody Combination Therapies and Methods Lapsed on the fee record Ended Jan 28, 2026 · High confidence | Lapsed on the fee record | Ended Jan 28, 2026 | High confidence |
| US 9,809,654 | Targeted cd1d molecules Lapsed on the fee record Ended Nov 7, 2025 · High confidence | Lapsed on the fee record | Ended Nov 7, 2025 | High confidence |
| US 7,858,559 | In Vitro Methods of Producing and Identifying Immunoglobulin Molecules in Eukaryotic Cells Formerly held Term ended Term ended Mar 30, 2025 · High confidence | Term ended | Term ended Mar 30, 2025 | High confidence |
| US 9,603,922 | Modulation of NKT Cell Activity with Antigen-Loaded CD1d Molecules Lapsed on the fee record Ended Mar 28, 2025 · High confidence | Lapsed on the fee record | Ended Mar 28, 2025 | High confidence |
| US 8,741,810 | In Vitro Methods of Producing and Identifying Immunoglobulin Molecules in Eukaryotic Cells Formerly held Term ended Term ended Jan 17, 2025 · High confidence | Term ended | Term ended Jan 17, 2025 | High confidence |